This article represents a synthesis of an extensive literature review and the authors' decades-long personal experience with both scleral buckling (SB) and vitrectomy for rhegmatogenous retinal detachment (RD). Presenting a coherent understanding of the pathophysiology and treatment of RD, the authors confirm numerous findings described in earlier publications but also challenge certain long-st...

PURPOSE To compare the incidence of posterior vitreous detachment (PVD) after femtosecond and microkeratome laser in situ keratomileusis (LASIK). SETTING Rowad Correction Centre, Cairo, Egypt (a private center affiliated to Cairo University). DESIGN Prospective, nonrandomized comparative unmasked study. METHODS The study was conducted at a single laser center. Eligible patients chose betw...

PURPOSE To clarify the relationship between variations in posterior vitreous detachments (PVDs) and visual prognoses in idiopathic epiretinal membranes (ERMs). METHODS In this retrospective, observational, and consecutive case series, we observed variations in PVDs in 37 patients (mean age, 65.7±11.0 years) with ERMs and followed them for 2 years. Three PVD types were found biomicroscopically...

Anomalous posterior vitreous detachment (PVD) plays a major role in the formation of anterior-posterior and tangential epiretinal traction. Advances in the tomographic analysis of vitreous traction vectors have highlighted the selected cases that can benefit from " parasurgical " approaches, providing a different perspective for therapeutic strategies. The symptomatic anterior-posterior tractio...

Pharmacologic Vitreolysis— Premise and Promise of the First Decade The term pharmacologic vitreolysis first appeared in the world’s literature one decade ago in the pages of the journal Retina.1 The coining of this term formalized a new field and was predicated on a premise and a promise. The premise was that we now understood enough about the molecular organization, structure, and physiology o...

Purpose. Endogenous endophthalmitis (EE) is a rare ocular disease caused by bacterial or fungal infection of intraocular spaces by hematogenous spread of pathogens from distant infectious loci in the body. We investigated the clinical characteristics and management of eyes with EE in ten consecutive patients. Methods. Ten patients (10 eyes) with EE treated at Tokyo Medical University Hospital i...

diabetic macular edema (dme) is an important cause of blindness in the working population and is currently challenging to treat. current interventions include focal laser or intravitreal injections. this article outlines a new treatment protocol based on the concept that peripheral ischemia is the introduction to angiogenesis, that will ultimately gather its momentum at the fovea. performing ex...